Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
7.75
-0.60 (-7.19%)
At close: Aug 19, 2026, 4:00 PM EDT
7.81
+0.06 (0.77%)
After-hours: Aug 19, 2026, 7:54 PM EDT
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $340.16 million as of August 19, 2026. Its market cap has decreased by -85.00% in one year.
Market Cap
340.16M
Enterprise Value
328.26M
1-Year Change
-85.00%
Ranking
Category
Stock Price
$7.75
ChartMarket Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $340.16M, an increase of 55.00%. That is a compound annual growth rate of 34.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 340.16M | -74.23% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| STAAR Surgical Company | 1.21B |
| Anteris Technologies Global | 918.06M |
| AngioDynamics | 647.68M |
| Sanara MedTech | 312.39M |
| Embecta | 290.66M |
| OraSure Technologies | 262.77M |
| Utah Medical Products | 223.54M |
| Pro-Dex | 214.39M |